TScan Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell TCRX and other ETFs, options, and stocks.

About TCRX

TScan Therapeutics, Inc. discovers and develops transformative T cell therapies (TCR-T) to treat liquid cancers, solid tumors and other serious diseases. Its platform identifies previously uncharacterized, clinically-derived shared T cell antigens and all off-target TCR interactions, to enable the development of efficacious TCR-Ts. 

CEO
Gavin MacBeath
CEOGavin MacBeath
Employees
194
Employees194
Headquarters
Waltham, Massachusetts
HeadquartersWaltham, Massachusetts
Founded
2018
Founded2018
Employees
194
Employees194

TCRX Key Statistics

Market cap
91.39M
Market cap91.39M
Price-Earnings ratio
-1.40
Price-Earnings ratio-1.40
Dividend yield
—
Dividend yield—
Average volume
533.73K
Average volume533.73K
High today
$1.71
High today$1.71
Low today
$1.57
Low today$1.57
Open price
$1.70
Open price$1.70
Volume
256.16K
Volume256.16K
52 Week high
$9.69
52 Week high$9.69
52 Week low
$1.02
52 Week low$1.02

Analyst ratings

100%

of 8 ratings
Buy
100%
Hold
0%
Sell
0%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.